In endometrial cancer patients, we observed by simple visual screening that the expression of CD40 and OAS2 was particularly variable in patient E9 at the different time points studied although the number of patients studied here didn’t allow us to conclude in terms of statistical significance. This evidence concerns the gene CD40 and endometrial cancer.